What Happened?
Shares of insulin delivery company Insulet Corporation (NASDAQ: PODD) jumped 3.4% in the afternoon session after Benchmark initiated coverage on the stock with a "Buy" rating and a $250 price target.
The new price target suggests a significant potential upside from the stock's recent trading levels, which were near its 52-week low. This positive analyst view came as the company, a leader in tubeless insulin pump technology, also announced the opening of its Middle East and North Africa regional headquarters in Riyadh, Saudi Arabia.
This new base will manage the company's operations, clinical engagement, and partner development across the region, signaling a strategic expansion into new markets.
After the initial pop the shares cooled down to $158.82, up 3% from previous close.
Is now the time to buy Insulet? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Insulet’s shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 6 months ago when the stock gained 6.8% on the news that comments from a key Federal Reserve official bolstered hopes for an interest rate cut.
New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally.
Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
Insulet is down 43.9% since the beginning of the year, and at $158.82 per share, it is trading 55% below its 52-week high of $352.82 from September 2025. Investors who bought $1,000 worth of Insulet’s shares 5 years ago would now be looking at only $704.25.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
